Aberrant activity of cyclin B1/Cdk1 is found in the radiation-derived tumor resistance [25], and inhibition of cyclin B1/Cdk1 activity enhances tumor radiosensitivity by increasing apoptosis [26], [27]. Here, CCNB1 is linked to neoplasm.